Skip to main content

Publications

featured publications

  • Emicizumab is well tolerated and effective in people with congenital hemophilia A regardless of age, severity of disease, or inhibitor status: a scoping review.

    Research and practice in thrombosis and haemostasis

    Authors: Guy Young, Steven W Pipe, Gili Kenet, Johannes Oldenburg, Mariam Safavi, Tuende Czirok, Francis Nissen, Johnny Mahlangu

  • Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A.

    Advances in therapy

    Authors: Johannes Oldenburg, Herve Chambost, Hai Liu, Charles Hawes, Xiaojun You, Xinqun Yang, Vanessa Newman, Tara M Robinson, Anthony J Hatswell, David Hinds, Sandra Santos, Margareth Ozelo

  • In-depth structure-function profiling of the complex formation between clotting factor VIII and heme.

    Thrombosis research

    Authors: Marie-T Hopp, Deniz Ugurlar, Behnaz Pezeshkpoor, Arijit Biswas, Anuradha Ramoji, Ute Neugebauer, Johannes Oldenburg, Diana Imhof

  • Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.

    Journal of thrombosis and haemostasis : JTH

    Authors: Bella Madan, Margareth C Ozelo, Priyanka Raheja, Emily Symington, Doris V Quon, Andrew D Leavitt, Steven W Pipe, Gillian Lowe, Gili Kenet, Mark T Reding, Jane Mason, Michael Wang, Annette von Drygalski, Robert Klamroth, Susan Shapiro, Hervé Chambost, Amy L Dunn, Johannes Oldenburg, Sheng-Chieh Chou, Flora Peyvandi, Carolyn M Millar, Dane Osmond, Hua Yu, Ebony Dashiell-Aje, Tara M Robinson, Johnny Mahlangu

  • Emicizumab is efficacious in people with hemophilia A with comorbidities aged ≥50 years: analysis of 4 phase III trials.

    Research and practice in thrombosis and haemostasis

    Authors: Víctor Jiménez-Yuste, Johannes Oldenburg, Eunice Tzeng, Elise Lim, Fabian Sanabria, Johnny Mahlangu

  • Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Cihan Ay, Mariasanta Napolitano, Abel Hassoun, Radovan Tomic, Cedric Martin, Wilfried Seifert, Karen Pinachyan, Johannes Oldenburg

  • Safety and Efficacy of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Untreated Patients with Hemophilia B.

    TH open : companion journal to thrombosis and haemostasis

    Authors: Richard Lemons, Michael Wang, Julie Curtin, Lynda Mae Lepatan, Christoph Male, Flora Peyvandi, Mario von Depka Prondzinski, Rongrong Wang, William McKeand, Wilfried Seifert, Johannes Oldenburg

  • Comprehensive Domain-Specific Analysis and IgG Profiling of anti-FVIII Antibodies using a bead-based multiplex immunoassay.

    Journal of thrombosis and haemostasis : JTH

    Authors: Behnaz Pezeshkpoor, Ann-Cristin Berkemeier, Kerstin Herbst, Thilo Albert, Jens Müller, Johannes Oldenburg

  • Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderReal.

    Research and practice in thrombosis and haemostasis

    Authors: Cihan Ay, Olga Benitez-Hidalgo, Gillian Gidley, Maria Elisa Mancuso, Davide Matino, Azusa Nagao, Laszlo Nemes, John Waller, Johannes Oldenburg

  • Physical activity and factor VIII levels in patients with haemophilia: A real-world prospective observational study.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Fabian Tomschi, Jamil Hmida, Steffen Herzig, Pia Ransmann, Marius Brühl, Alexander Schmidt, Marie Herzig, Georg Goldmann, Andreas C Strauß, Johannes Oldenburg, Heinrich Richter, Thomas Hilberg